The stock of Northann Corp (NCL) has gone down by -19.16% for the week, with a 49.83% rise in the past month and a 25.58% rise in the past quarter. The volatility ratio for the week is 36.93%, and the volatility levels for the past 30 days are 23.52% for NCL. The simple moving average for the past 20 days is 19.83% for NCL’s stock, with a -27.82% simple moving average for the past 200 days.
Is It Worth Investing in Northann Corp (AMEX: NCL) Right Now?
The stock has a 36-month beta value of -0.91.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NCL is 14.55M, and at present, short sellers hold a 0.81% of that float. On November 18, 2024, the average trading volume of NCL was 5.50M shares.
NCL) stock’s latest price update
Northann Corp (AMEX: NCL)’s stock price has plunge by 15.98relation to previous closing price of 0.23. Nevertheless, the company has seen a -19.16% plunge in its stock price over the last five trading sessions. newsfilecorp.com reported 2024-11-07 that Halifax, Nova Scotia–(Newsfile Corp. – November 7, 2024) – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company”, “Sona”) is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro, has been invited to showcase Sona’s developing Targeted Hyperthermia Therapy (“THT”) cancer treatment today at the Nanotechnology Characterization Laboratory (“NCL”). Sona will be one of six commercial and academic collaborators to present its research at the NCL’s 20th anniversary “Advancing Medical Applications of Cancer Nanotechnology” symposium.
NCL Trading at 39.29% from the 50-Day Moving Average
After a stumble in the market that brought NCL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.51% of loss for the given period.
Volatility was left at 23.52%, however, over the last 30 days, the volatility rate increased by 36.93%, as shares surge +49.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +59.39% upper at present.
During the last 5 trading sessions, NCL fell by -19.16%, which changed the moving average for the period of 200-days by -72.36% in comparison to the 20-day moving average, which settled at $0.2253. In addition, Northann Corp saw -81.88% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NCL
Current profitability levels for the company are sitting at:
- -0.41 for the present operating margin
- 0.1 for the gross margin
The net margin for Northann Corp stands at -0.5. The total capital return value is set at -5.31. Equity return is now at value -526.66, with -54.03 for asset returns.
Based on Northann Corp (NCL), the company’s capital structure generated 0.89 points at debt to capital in total, while cash flow to debt ratio is standing at -0.46. The debt to equity ratio resting at 7.76. The interest coverage ratio of the stock is -3.76.
Currently, EBITDA for the company is -4.08 million with net debt to EBITDA at -0.84. When we switch over and look at the enterprise to sales, we see a ratio of 0.81. The receivables turnover for the company is 5.99for trailing twelve months and the total asset turnover is 1.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.53.
Conclusion
To sum up, Northann Corp (NCL) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
